Delivery Order SPE2DB20D1050-SPE2DB24FH73Q

Award Date 6/17/24
Potential Completion Date 6/18/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for $2,584.79. The contract is a Firm Fixed Price Delivery Order for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S" to the Defense Logistics Agency (DLA). The $2,558.92 firm fixed-price delivery order contract has a completion date of December 11, 2024. The contract was not set aside for any specific business category. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a delivery order valued at $1,372.80 for the supply of REFRESH PLUS 0.5% EYE DROPS 30S. The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen, a large pharmaceutical distribution company, holds multiple federal contracts with the DLA and Department of Justice Federal Bureau of Investigation to provide a wide range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product "REFRESH PLUS 0.5% EYE DROPS UD 70S" to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $2,681.59, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This contract award, valued at $3,990.58, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of REFRESH PLUS 0.5% EYE DROPS UD 50S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The $1,869.12 delivery order contract is for the supply of 4565378714 REFRESH PLUS 0.5% EYE DROPS UD 50S and has a period of performance through August 8, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides medical products and supplies to various federal agencies, with a significant focus on the military and veterans' healthcare systems. This award is part of a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,905.90 contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S" pharmaceutical products to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen...
This federal contract award, valued at $1,716.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4564741705 ! REFRESH PLUS 0.5% EYE DROPS 30S, a pharmaceutical product, to support the Department of Defense (DoD) and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Refresh Plus 0.5% eye drops in unit dose packaging. The $1,658.52 Firm Fixed Price Delivery Order contract has a completion date of May 29, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,504.18 for the procurement of 4566596148 - REFRESH PLUS 0.5% EYE DROPS UD 70S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
  • SPE2DB20D1050
    Indefinite Delivery Contract
  • SPE2DB20D1050-SPE2DB24FH73Q
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4564931985 REFRESH PLUS 0.5% EYE DROPS 30S to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $1,731.90 and a completion date of June 18, 2024. This award is not associated with a set-aside program.

Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 9/16/24, 10:50 AM